Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Psychopharmacology
|
August 29, 2012
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
Jian-Jun Ou, Yi Xu, Hong-Hui Chen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
March 4, 2010
Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone
David C Henderson, Bikash Sharma, Xiaoduo Fan, et al.
Schizophrenia Research
|
May 14, 2011
Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia
David C Henderson, Oliver Freudenreich, Christina P C Borba, et al.
Schizophrenia Research
|
August 27, 2014
Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings
Wenbin Guo, Maorong Hu, Xiaoduo Fan, et al.
Harm Reduction Journal
|
May 29, 2019
Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China
Lei Zhang, Jiayi Bao, Amy Harrington, et al.
Journal of Psychiatric Practice
|
July 24, 2009
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine
David C Henderson, Xiaoduo Fan, Bikash Sharma, et al.
Schizophrenia Research
|
June 4, 2018
Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia
Xiuxia Yuan, Peifen Zhang, Yaping Wang, et al.
Plos One
|
April 16, 2015
Neural correlates of the preserved inhibition of return in schizophrenia
Yingying Tang, Yan Li, Kaiming Zhuo, et al.
JAMA Psychiatry
|
February 22, 2018
Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis
Donald C Goff, Botao Zeng, Babak A Ardekani, et al.
Journal of Clinical Psychopharmacology
|
June 11, 2009
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients
David C Henderson, Xiaoduo Fan, Paul M Copeland, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Psychopharmacology
|
August 29, 2012
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia
Jian-Jun Ou, Yi Xu, Hong-Hui Chen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
March 4, 2010
Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone
David C Henderson, Bikash Sharma, Xiaoduo Fan, et al.
Schizophrenia Research
|
May 14, 2011
Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia
David C Henderson, Oliver Freudenreich, Christina P C Borba, et al.
Schizophrenia Research
|
August 27, 2014
Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings
Wenbin Guo, Maorong Hu, Xiaoduo Fan, et al.
Harm Reduction Journal
|
May 29, 2019
Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China
Lei Zhang, Jiayi Bao, Amy Harrington, et al.
Journal of Psychiatric Practice
|
July 24, 2009
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine
David C Henderson, Xiaoduo Fan, Bikash Sharma, et al.
Schizophrenia Research
|
June 4, 2018
Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia
Xiuxia Yuan, Peifen Zhang, Yaping Wang, et al.
Plos One
|
April 16, 2015
Neural correlates of the preserved inhibition of return in schizophrenia
Yingying Tang, Yan Li, Kaiming Zhuo, et al.
JAMA Psychiatry
|
February 22, 2018
Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis
Donald C Goff, Botao Zeng, Babak A Ardekani, et al.
Journal of Clinical Psychopharmacology
|
June 11, 2009
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients
David C Henderson, Xiaoduo Fan, Paul M Copeland, et al.
Page
of 11